Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages

Ying Liu, Keqiang Chen, Chunyan Wang, Wanghua Gong, Teizo Yoshimura, Mingyong Liu, Ji Ming Wang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

FPR2 (Fpr2 in mouse) is a G-protein-coupled receptor interacting with bacterial and host-derived chemotactic agonists. Fpr2 supports innate and adaptive immune responses as illustrated by the reduction in severity of allergic airway inflammation in Fpr2-KO mice, due to impaired trafficking of antigen-presenting dendritic cells (DC). The aim of this study is to examine the role of Fpr2 in host antitumor responses. We found that Fpr2-KO mice bearing subcutaneously implanted Lewis lung carcinoma (LLC) cells exhibited significantly shortened survival than normal mice due to more rapidly growing tumors. In contrast, in Fpr2-transgenic mice overexpressing Fpr2, subcutaneously implanted LLC tumors grew more slowly than those in wild-type (WT) littermates. Investigation of tumor tissues revealed an increased number of macrophages associated with tumors grown in Fpr2-KO mice. Macrophages derived from Fpr2-KO mice showed a more potent chemotactic response to LLC-derived supernatant (LLC Sup), which could be neutralized by an anti-CCL2 antibody. The increased chemotaxis of Fpr2-KO mouse macrophages in response to LLC Sup was due to their higher level expression of CCR4, a chemokine receptor that also recognizes the ligand CCL2. Furthermore, macrophages from Fpr2-KO mice acquired an M2 phenotype after stimulation with LLC Sup. These results suggest that Fpr2 plays an important role in host defense against implanted LLC by sustaining macrophages in an M1 phenotype with more potent antitumor activities.

Original languageEnglish
Pages (from-to)550-560
Number of pages11
JournalCancer Research
Volume73
Issue number2
DOIs
Publication statusPublished - Jan 15 2013
Externally publishedYes

Fingerprint

Cell Surface Receptors
Lewis Lung Carcinoma
Macrophages
Neoplasms
Phenotype
Chemokine Receptors
Adaptive Immunity
Antigen-Presenting Cells
Chemotaxis
G-Protein-Coupled Receptors
Innate Immunity
Dendritic Cells
Transgenic Mice
Anti-Idiotypic Antibodies
Ligands
Inflammation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. / Liu, Ying; Chen, Keqiang; Wang, Chunyan; Gong, Wanghua; Yoshimura, Teizo; Liu, Mingyong; Wang, Ji Ming.

In: Cancer Research, Vol. 73, No. 2, 15.01.2013, p. 550-560.

Research output: Contribution to journalArticle

Liu, Ying ; Chen, Keqiang ; Wang, Chunyan ; Gong, Wanghua ; Yoshimura, Teizo ; Liu, Mingyong ; Wang, Ji Ming. / Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. In: Cancer Research. 2013 ; Vol. 73, No. 2. pp. 550-560.
@article{2e0eaceec4f942ab8a54e99a395b163e,
title = "Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages",
abstract = "FPR2 (Fpr2 in mouse) is a G-protein-coupled receptor interacting with bacterial and host-derived chemotactic agonists. Fpr2 supports innate and adaptive immune responses as illustrated by the reduction in severity of allergic airway inflammation in Fpr2-KO mice, due to impaired trafficking of antigen-presenting dendritic cells (DC). The aim of this study is to examine the role of Fpr2 in host antitumor responses. We found that Fpr2-KO mice bearing subcutaneously implanted Lewis lung carcinoma (LLC) cells exhibited significantly shortened survival than normal mice due to more rapidly growing tumors. In contrast, in Fpr2-transgenic mice overexpressing Fpr2, subcutaneously implanted LLC tumors grew more slowly than those in wild-type (WT) littermates. Investigation of tumor tissues revealed an increased number of macrophages associated with tumors grown in Fpr2-KO mice. Macrophages derived from Fpr2-KO mice showed a more potent chemotactic response to LLC-derived supernatant (LLC Sup), which could be neutralized by an anti-CCL2 antibody. The increased chemotaxis of Fpr2-KO mouse macrophages in response to LLC Sup was due to their higher level expression of CCR4, a chemokine receptor that also recognizes the ligand CCL2. Furthermore, macrophages from Fpr2-KO mice acquired an M2 phenotype after stimulation with LLC Sup. These results suggest that Fpr2 plays an important role in host defense against implanted LLC by sustaining macrophages in an M1 phenotype with more potent antitumor activities.",
author = "Ying Liu and Keqiang Chen and Chunyan Wang and Wanghua Gong and Teizo Yoshimura and Mingyong Liu and Wang, {Ji Ming}",
year = "2013",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-12-2290",
language = "English",
volume = "73",
pages = "550--560",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages

AU - Liu, Ying

AU - Chen, Keqiang

AU - Wang, Chunyan

AU - Gong, Wanghua

AU - Yoshimura, Teizo

AU - Liu, Mingyong

AU - Wang, Ji Ming

PY - 2013/1/15

Y1 - 2013/1/15

N2 - FPR2 (Fpr2 in mouse) is a G-protein-coupled receptor interacting with bacterial and host-derived chemotactic agonists. Fpr2 supports innate and adaptive immune responses as illustrated by the reduction in severity of allergic airway inflammation in Fpr2-KO mice, due to impaired trafficking of antigen-presenting dendritic cells (DC). The aim of this study is to examine the role of Fpr2 in host antitumor responses. We found that Fpr2-KO mice bearing subcutaneously implanted Lewis lung carcinoma (LLC) cells exhibited significantly shortened survival than normal mice due to more rapidly growing tumors. In contrast, in Fpr2-transgenic mice overexpressing Fpr2, subcutaneously implanted LLC tumors grew more slowly than those in wild-type (WT) littermates. Investigation of tumor tissues revealed an increased number of macrophages associated with tumors grown in Fpr2-KO mice. Macrophages derived from Fpr2-KO mice showed a more potent chemotactic response to LLC-derived supernatant (LLC Sup), which could be neutralized by an anti-CCL2 antibody. The increased chemotaxis of Fpr2-KO mouse macrophages in response to LLC Sup was due to their higher level expression of CCR4, a chemokine receptor that also recognizes the ligand CCL2. Furthermore, macrophages from Fpr2-KO mice acquired an M2 phenotype after stimulation with LLC Sup. These results suggest that Fpr2 plays an important role in host defense against implanted LLC by sustaining macrophages in an M1 phenotype with more potent antitumor activities.

AB - FPR2 (Fpr2 in mouse) is a G-protein-coupled receptor interacting with bacterial and host-derived chemotactic agonists. Fpr2 supports innate and adaptive immune responses as illustrated by the reduction in severity of allergic airway inflammation in Fpr2-KO mice, due to impaired trafficking of antigen-presenting dendritic cells (DC). The aim of this study is to examine the role of Fpr2 in host antitumor responses. We found that Fpr2-KO mice bearing subcutaneously implanted Lewis lung carcinoma (LLC) cells exhibited significantly shortened survival than normal mice due to more rapidly growing tumors. In contrast, in Fpr2-transgenic mice overexpressing Fpr2, subcutaneously implanted LLC tumors grew more slowly than those in wild-type (WT) littermates. Investigation of tumor tissues revealed an increased number of macrophages associated with tumors grown in Fpr2-KO mice. Macrophages derived from Fpr2-KO mice showed a more potent chemotactic response to LLC-derived supernatant (LLC Sup), which could be neutralized by an anti-CCL2 antibody. The increased chemotaxis of Fpr2-KO mouse macrophages in response to LLC Sup was due to their higher level expression of CCR4, a chemokine receptor that also recognizes the ligand CCL2. Furthermore, macrophages from Fpr2-KO mice acquired an M2 phenotype after stimulation with LLC Sup. These results suggest that Fpr2 plays an important role in host defense against implanted LLC by sustaining macrophages in an M1 phenotype with more potent antitumor activities.

UR - http://www.scopus.com/inward/record.url?scp=84872577084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872577084&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-2290

DO - 10.1158/0008-5472.CAN-12-2290

M3 - Article

C2 - 23139214

AN - SCOPUS:84872577084

VL - 73

SP - 550

EP - 560

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 2

ER -